MicroRNA-630 suppresses epithelial-to-mesenchymal transition by regulating FoxM1 in gastric cancer cells
- 作者: Feng J.1, Wang X.2, Zhu W.3, Chen S.3, Feng C.1
- 
							隶属关系: 
							- Department of Gastroenterology
- Department of Oncology
- Department of Respiratory Medicine
 
- 期: 卷 82, 编号 6 (2017)
- 页面: 707-714
- 栏目: Review
- URL: https://journals.rcsi.science/0006-2979/article/view/151409
- DOI: https://doi.org/10.1134/S0006297917060074
- ID: 151409
如何引用文章
详细
In the present study, we investigated the functional role of microRNA (miR)-630 in epithelial-to-mesenchymal transition (EMT) of gastric cancer (GC) cells, as well as the regulatory mechanism. Cells of human GC cell line SGC 7901 were transfected with miR-630 mimic or miR-630 inhibitor. The transfection efficiency was confirmed by qRT-PCR. Cell migration and invasion were determined by Transwell assay. Protein expression of E-cadherin, vimentin, and Forkhead box protein M1 (FoxM1) was tested by Western blot. Moreover, the expression of FoxM1 was elevated or suppressed, and then the effects of miR-630 abnormal expression on EMT and properties of migration and invasion were examined again, as well as protein expression of Ras/phosphoinositide 3-kinase (PI3K)/AKT related factors. The results showed that (i) the EMT and properties of migration and invasion were statistically decreased by overexpression of miR-630 compared to the control group but markedly increased by suppression of miR-630. However, (ii) abnormal expression of FoxM1 reversed these effects in GC cells. Moreover, (iii) expression of GTP-Rac1, p-PI3K, and p-AKT was decreased by miR-630 overexpression but increased by FoxM1 overexpression. (iv) The decreased levels of GTP-Rac1, p-PI3K, and p-AKT induced by miR-630 overexpression were dramatically elevated by simultaneous overexpression of FoxM1. In conclusion, our results suggest that miR-630 might be a tumor suppressor in GC cells. MiR-630 suppresses EMT by regulating FoxM1 in GC cells, supposedly via inactivation of the Ras/PI3K/AKT pathway.
作者简介
Jing Feng
Department of Gastroenterology
														Email: fengchangwei373@126.com
				                					                																			                												                	中国, 							Zhengzhou, Henan Province, 450014						
Xiaojuan Wang
Department of Oncology
														Email: fengchangwei373@126.com
				                					                																			                												                	中国, 							Zhengzhou, Henan Province, 450052						
Weihua Zhu
Department of Respiratory Medicine
														Email: fengchangwei373@126.com
				                					                																			                												                	中国, 							Zhengzhou, Henan Province, 450047						
Si Chen
Department of Respiratory Medicine
														Email: fengchangwei373@126.com
				                					                																			                												                	中国, 							Zhengzhou, Henan Province, 450047						
Changwei Feng
Department of Gastroenterology
							编辑信件的主要联系方式.
							Email: fengchangwei373@126.com
				                					                																			                												                	中国, 							Zhengzhou, Henan Province, 450014						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					